Akso Health Group
Financial ratios & Valuation

Historical Multiples (2015 – 2024)

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 TTM Median
Valuation Ratios
Price/Earnings ratio
-1.73K171.4570.788.3131.94-0.28-0.90-1.99-0.62-5.42-0.36-0.28
Price/Sales ratio
130.5851.0026.465.072.881.7916.325.320.6121.261.681.79
Price/Book Value ratio
181.0743.2925.813.881.390.421.652.730.930.371.861.39
Price/Cash Flow ratio
234.5586.3574.076.20-102.09-0.362.84-3.89-2.4938.000.48-102.09
Price/Free Cash Flow ratio
256.7987.8676.776.24-66.04-0.362.84-3.88-2.4938.000.48-66.04
Price/Earnings Growth ratio
N/A-0.150.480.01-0.340.000.010.030.010.08-0.03-0.34
Dividend Yield
N/AN/AN/AN/A11.06%N/AN/AN/AN/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
65.44%80.16%77.53%92.07%87.93%56.32%68.96%14.51%9.62%5.05%-26.71%56.32%
Operating Profit Margin
-6.42%34.81%43.25%70.74%8.31%-322.04%-1547.05%-239.79%-108.23%-357.78%-436.90%-322.04%
Pretax Profit Margin
-6.59%35.03%44.03%71.35%12.07%-585.30%-1770.39%-264.90%-99.12%-376.57%-424.79%-585.30%
Net Profit Margin
-7.53%29.74%37.39%61.05%9.02%-622.63%-1797.91%-266.98%-99.26%-391.77%-466.08%-622.63%
Effective Tax Rate
-14.31%15.07%15.08%14.40%25.28%-6.37%-1.55%-0.78%-0.13%-0.27%-6.40%-6.37%
Return on Assets
-4.73%15.80%30.19%39.95%3.19%-90.83%-99.57%-33.24%-63.94%-6.66%-309.15%-90.83%
Return On Equity
-10.45%25.25%36.46%46.75%4.37%-148.01%-182.68%-137.17%-149.95%-6.83%-359.18%-148.01%
Return on Capital Employed
-8.91%29.54%42.17%54.18%3.47%-53.98%-157.19%-123.18%-161.39%-6.24%-482.07%-53.98%
Liquidity Ratios
Current Ratio
N/AN/AN/A6.843.674.902.08N/AN/AN/A1.714.90
Quick Ratio
0.45-1.44-0.196.843.803.83K3.081.111.6339.461.693.83K
Cash ratio
0.230.933.945.562.151.071.040.570.6823.691.191.19
Days of Sales Outstanding
N/AN/AN/A1.892.491.01K2.17K1.15K213.13N/A111.012.49
Days of Inventory outstanding
N/A3.36K2.02K0.00-102.69-2.85M-9.63K527.4451.6730.44N/A-102.69
Operating Cycle
N/A3.36K2.02K1.89-100.20-2.84M-7.46K1.68K264.8030.4427.37-100.20
Days of Payables Outstanding
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Cash Conversion Cycle
N/A3.36K2.02K1.89-100.20-2.84M-7.46K1.68K264.8030.44111.01-100.20
Debt Ratios
Debt Ratio
N/AN/AN/AN/A0.110.250.31N/A0.480.010.390.11
Debt Equity Ratio
N/AN/AN/AN/A0.150.410.57N/A1.130.010.660.15
Long-term Debt to Capitalization
N/AN/AN/AN/A0.130.29N/AN/A0.02N/AN/A0.29
Total Debt to Capitalization
N/AN/AN/AN/A0.130.290.36N/A0.530.01N/A0.29
Interest Coverage Ratio
N/AN/AN/AN/AN/A-27.28-12.60N/AN/AN/A-135.88-27.28
Cash Flow to Debt Ratio
N/AN/AN/AN/A-0.08-2.791.00N/A-0.320.67N/A-0.08
Company Equity Multiplier
2.201.591.201.171.361.621.834.122.341.021.661.36
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
0.550.590.350.81-0.02-4.885.73-1.36-0.240.553.49-0.02
Free Cash Flow / Operating Cash Flow Ratio
0.910.980.960.991.541.0011.00110.991.00
Cash Flow Coverage Ratio
N/AN/AN/AN/A-0.08-2.791.00N/A-0.320.67N/A-0.08
Short Term Coverage Ratio
N/AN/AN/AN/AN/AN/A1.00N/A-0.330.677.53N/A
Dividend Payout Ratio
N/AN/AN/AN/A353.31%N/AN/AN/AN/AN/AN/AN/A